Laquinimod in Participants With Systemic Lupus Erythematosus Active Lupus Nephritis

Study Title

Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis

Teva Identifier

LN-LAQ-201 | 2010-018329-20

ClinicalTrials.gov Identifier

NCT01085097

Study Status

Completed

Trial Condition(s)

Lupus Nephritis

Interventions

Drug: laquinimod | Drug: Mycophenolate Mofetil | Drug: prednisolone/prednisone | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
inflammation and infections icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 75 Years

Trial Duration

07/01/2010 - 12/01/2012

Phase

Phase 2

Study Type

Interventional